Female Infertility Diagnosis and Treatment Market
Global Female Infertility Diagnosis and Treatment Market Size, Share & Trends Analysis Report by Diagnosis (Ovulation Testing, Hysterosalpingography (HSG), Hysteroscopy, Imaging Testing, Ovarian Reserve Testing, Hormonal Level Testing, Genetic Testing, and Others)by Treatment (Drugs, Surgery, Intrauterine Insemination (IUI), Assisted Reproductive Technology (ART)) by End User(Hospitals and Clincis, Homecare, and Pathology and Diagnostic Centers) Forecast 2022-2028
The global female infertility diagnosis and treatment market is anticipated to grow at a significant CAGR of 5.6% during the forecast period (2022-2028). Increasing infertility and changing lifestyles drive the growth of the global female infertility diagnosis and treatment market. For instance, according to the center for disease control and prevention in December 2021, in the US, around 13.8% of women aged 15-49 have impaired fecundity, and 26% of married women of the same age group are suffered from impaired fecundity. This, in turn, is expected to propel the demand for female infertility diagnosis and treatment. Furthermore, the rising trends of surrogacy, the growing infertility rate among females, and new technologies to avoid multiple embryo implants are estimated to be the major factors that are contributing to the growth of the market.
However, certain factors restrained the growth of the market, such as the high cost of infertility treatment, and the low accuracy rate of the treatment. Moreover, the social stigma related to infertility treatment is another factor that may hinder the global female infertility diagnosis and treatment market across the globe.
Impact of COVID-19 Pandemic on Global Female Infertility Diagnosis and Treatment Market
The COVID-19 pandemic has had adverse effects on the market. The global fertility rates have been in decline for years, and the COVID-19 pandemic has amplified this trend, particularly for women. A report published by, the National Bureau of Economic Research in February 2022, shows that many US women planned to delay or avoid childbearing as the economy slowed during the COVID-19 pandemic, and access to contraception and abortion fell, as reproductive health centers across the world temporarily closed or reduced their capacity. Moreover, according to the 2020 Guttmacher Survey of Reproductive Health, 33 percent of women had to delay or cancel visiting their health care provider or had trouble getting their birth control due to the pandemic
Segmental Outlook
The global female infertility diagnosis and treatment market is segmented on the basis of diagnosis, treatment, and end-user. Based on the diagnosis, the market is segmented into the ovulation testing, ovarian reserve testing, hormonal level testing, hysterosalpingography (HSG), hysteroscopy, imaging testing, genetic testing, and others. The ovulation testing segment is anticipated to show a significant growth rate in the market, owing to technological advancements in ovulation test kits to get accurate and reliable results. Based on treatment, the market is fragmented into drugs, surgery, IUI, and ART. The market is further analyzed based on end-users of the female infertility diagnosis and treatment, including hospitals and clinics, homecare, and pathology and diagnostic centers.
Global Female Infertility Diagnosis and Treatment Market Share by Treatment, 2021(%)
Assisted Reproductive Technology (ART) is estimated to propel at a considerable growth rate in the market
Among the type of treatments, the ART segment is projected to witness a considerable growth rate during the forecast period. The growth is driven by the factors such as the newly invented techniques that are used to treat a condition which include, in-vitro fertilization(IVF), artificial insemination(AI-IUI), and frozen embryo transfer(FET), and gamete intrafallopian transfer(GIFT). Furthermore, a rise in the funding from private and government organizations for infertility services, and an increased awareness regarding infertility treatment and surrogacy, drive the growth of the segment in the global female infertility diagnosis and treatment market.
Regional Outlooks
The global female infertility diagnosis and treatment market is further segmented based on geography including North America (the US, and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East & Africa, and Latin America). North America is anticipated to hold a significant share in the global market. The declining fertility rates, the rising median age of first-time pregnancy, and the increase in healthcare expenditure are the major factors that are contributing to the market growth in North America. Moreover, the presence of major market players in this region, including Pfizer Inc. North America, followed by Europe are expected to boost the global female infertility diagnosis and treatment market during the forecast period.
Global Female Infertility Diagnosis and Treatment Market Growth, by Region 2022-2028
Asia-Pacific expected to propel with Significant Growth in the Global Female Infertility Diagnosis and Treatment Market
Asia-Pacific is estimated to project a significant growth rate in the global market. The declining birth rate in some major countries of Asia-Pacific, such as Japan, Singapore, Taiwan, and South Korea is a major factor to drive the growth of the female infertility diagnosis and treatment market in the region. The government of countries such as South Korea and Singapore is offering IVF treatment at subsidized rates to improve the birth rate in the countries. New product developments launched by market players are further aid in market growth. For instance, in April 2022, Israel-based Embryonics announced its first collaboration in India with the Jaslok-FertileTree International fertility center. The newly set up partnership will aim to help increase the success rate of fertility treatment in the Indian subcontinent. Embryonic uses tens of thousands of data points from large clinics in the US, Isreal, Europe, and Asia-Pacific, and the first product to reach the market is UBER, CE. UBER, is equipped with cloud-based software that uses tie lapse videos or single images of blastocysts to predict implantation probability, automatically annotate morphokinetic events, and assist embryo selection using a data-driven approach.
Market Players Outlook
The prominent players contributing globally in the female infertility diagnosis and treatment market are Bayer AG, Church & Dwight Co. Inc., Genea Ltd., Pfizer Inc., Vitrolife Sweden AB, Esco Group, Fairhaven Health, Ferring B.V., and others. These key manufacturers are adopting various strategies like new product launches, mergers and acquisitions, partnerships and collaborations, and many others to thrive in a competitive environment. For instance, in January 2022, Eggschain announced a partnership with the Boston IVF chain of 30 fertility clinics in the US. With this partnership, the eggs chain aids in the tracking of cryogenically preserved sperm which is to be used for in vitro fertilization(IVF) through blockchain technology provided by the eggs chain.
The Report Covers
- Market value data analysis of 2021 and forecast to 2028.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global female infertility diagnosis and treatment market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
1. Report Summary
• Current Industry Analysis and Growth Potential Outlook
• Impact of COVID-19 on the Global Female Infertility Diagnosis and Treatment Market
• Recovery Scenario of Global Female Infertility Diagnosis and Treatment Market
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. BY Region
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight and Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Competitive Landscape
3.1. Key CompanyAnalysis
3.1.1. Bayer AG
3.1.1.1. Overview
3.1.1.2. Financial Analysis
3.1.1.3. SWOT Analysis
3.1.1.4. Recent Developments
3.1.2. Church & Dwight Co. Inc
3.1.2.1. Overview
3.1.2.2. Financial Analysis
3.1.2.3. SWOT Analysis
3.1.2.4. Recent Developments
3.1.3. Genea Ltd.
3.1.3.1. Overview
3.1.3.2. Financial Analysis
3.1.3.3. SWOT Analysis
3.1.3.4. Recent Developments
3.1.4. Pfizer Inc
3.1.4.1. Overview
3.1.4.2. Financial Analysis
3.1.4.3. SWOT Analysis
3.1.4.4. Recent Developments
3.1.5. Vitrolife Sweden AB
3.1.5.1. Overview
3.1.5.2. Financial Analysis
3.1.5.3. SWOT Analysis
3.1.5.4. Recent Developments
3.2. Key Strategy Analysis
3.3. Impact of Covid-19 on Key Players
4. Market Segmentation
4.1. Global Female Infertility Diagnosis and Treatment Market by Diagnosis
4.1.1. Ovulation Testing
4.1.2. Hysterosalpingography (HSG)
4.1.3. Hysteroscopy
4.1.4. Imaging Testing
4.1.5. Ovarian Reserve Testing
4.1.6. Hormonal Level Testing
4.1.7. Genetic Testing
4.1.8. Others (Laparoscopy)
4.2. Global Female Infertility Diagnosis and Treatment Market by Treatment
4.2.1. Drugs
4.2.2. Surgery
4.2.3. Intrauterine Insemination (IUI)
4.2.4. Assisted Reproductive Technology (ART)
4.3. Global Female Infertility Diagnosis and Treatment Market by End-User
4.3.1. Hospitals and Clinics
4.3.2. Homecare
4.3.3. Pathology and Diagnostic Centers
5. Regional Analysis
5.1. North America
5.1.1. United States
5.1.2. Canada
5.2. Europe
5.2.1. UK
5.2.2. Germany
5.2.3. Italy
5.2.4. Spain
5.2.5. France
5.2.6. Rest of Europe
5.3. Asia-Pacific
5.3.1. China
5.3.2. India
5.3.3. Japan
5.3.4. South Korea
5.3.5. Rest of Asia-Pacific
5.4. Rest of the World
6. Company Profiles
6.1. Cook Group Inc.
6.2. Eli Lilly & Co.
6.3. Esco Group
6.4. Fairhaven Health
6.5. Ferring B.V.
6.6. Fujifilm Irvine Scientific, Inc.
6.7. GlaxoSmithKline Plc.
6.8. Merck KGaA
6.9. Princeton BioMeditech Corp.
6.10. Tempest Therapeutics, Inc.
1. GLOBAL FEMALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2021-2028($ MILLION)
2. GLOBAL OVULATION TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
3. GLOBAL HYSTEROSALPINGOGRAPHY MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
4. GLOBAL HYSTEROSCOPY MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
5. GLOBAL IMAGING TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
6. GLOBAL OVARIAN RESERVE TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
7. GLOBAL HORMONAL LEVEL TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
8. GLOBAL GENETIC TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
9. GLOBAL OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
10. GLOBAL FEMALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2021-2028 ($ MILLION)
11. GLOBAL DRUGS FOR FEMALE INFERTILITY MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
12. GLOBAL SURGERY FOR FEMALE INFERTILITY MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
13. GLOBAL INTRAUTERINE INSEMINATION (IUI) FOR FEMALE INFERTILITY MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
14. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY (ART) FOR FEMALE INFERTILITY MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
15. GLOBAL FEMALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
16. GLOBAL FEMALE INFERTILITY TREATMENT IN HOSPITALS AND CLINICS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
17. GLOBAL FEMALE INFERTILITY TREATMENT IN HOMECARE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
18. GLOBAL FEMALE INFERTILITY IN PATHOLOGY AND DIAGNOSTIC CENTERS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
19. GLOBAL FEMALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY,2021-2028 ($ MILLION)
20. NORTH AMERICAN FEMALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
21. NORTH AMERICAN FEMALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2021-2028 ($ MILLION)
22. NORTH AMERICAN FEMALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2021-2028 ($ MILLION)
23. NORTH AMERICAN FEMALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
24. EUROPEAN FEMALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
25. EUROPEAN FEMALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2021-2028 ($ MILLION)
26. EUROPEAN FEMALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2021-2028 ($ MILLION)
27. EUROPEAN FEMALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
28. ASIA-PACIFIC FEMALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
29. ASIA-PACIFIC FEMALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2021-2028 ($ MILLION)
30. ASIA-PACIFIC FEMALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2021-2028 ($ MILLION)
31. ASIA-PACIFIC FEMALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
32. REST OF THE WORLD FEMALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2021-2028 ($ MILLION)
33. REST OF THE WORLD FEMALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2021-2028 ($ MILLION)
34. REST OF THE WORLD FEMALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
1. IMPACT OF COVID-19 ON GLOBAL FEMALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET, 2021-2028 ($ MILLION)
2. IMPACT OF COVID-19 ON GLOBAL FEMALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET BY SEGMENT, 2021-2028 ($ MILLION)
3. RECOVERY OF GLOBAL FEMALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET, 2021-2028 (%)
4. GLOBAL FEMALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET SHARE BY DIAGNOSIS, 2021 VS 2028 (%)
5. GLOBAL OVULATION TESTING MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
6. GLOBAL HYSTEROSALPINGOGRAPHY MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
7. GLOBAL HYSTEROSCOPY MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
8. GLOBAL IMAGING TESTING MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
9. GLOBAL OVARIAN RESERVE TESTING MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
10. GLOBAL HORMONAL LEVEL TESTING MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
11. GLOBAL GENETIC TESTING MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
12. GLOBAL OTHER DIAGNOSIS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
13. GLOBAL FEMALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET SHARE BY TREATMENT, 2021 VS 2028 (%)
14. GLOBAL DRUGS FOR FEMALE INFERTILITY MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
15. GLOBALSURGERY FOR FEMALE INFERTILITY MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
16. GLOBAL INTRAUTERINE INSEMINATION (IUI) FOR FEMALE INFERTILITY MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
17. GLOBAL FEMALE INFERTILITY DIAGNOSIS AND TREATMENT IN ANALGESIA MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
18. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY (ART) FOR FEMALE INFERTILITY MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
19. GLOBAL FEMALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET SHARE BY END-USER, 2021 VS 2028 (%)
20. GLOBAL FEMALE INFERTILITY DIAGNOSIS AND TREATMENT IN HOSPITALS AND CLINICS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
21. GLOBAL FEMALE INFERTILITY DIAGNOSIS AND TREATMENT IN HOMECARE MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
22. GLOBAL FEMALE INFERTILITY DIAGNOSIS AND TREATMENT IN PATHOLOGY AND DIAGNOSTIC CENTERS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
23. US FEMALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
24. CANADA FEMALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
25. UK FEMALE INFERTILITY DIAGNOSIS AND TREATMEN T MARKET SIZE, 2021-2028 ($ MILLION)
26. FRANCE FEMALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
27. GERMANY FEMALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
28. ITALY FEMALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
29. SPAIN FEMALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
30. REST OF EUROPE FEMALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
31. INDIA FEMALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
32. CHINA FEMALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
33. JAPAN FEMALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
34. SOUTH KOREA FEMALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
35. REST OF ASIA-PACIFIC FEMALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
36. REST OF THE WORLD FEMALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
